Sulfated lactosyl archaeol (SLA) archaeosomes as a vaccine adjuvant

IF 4.8 4区医学

Human Vaccines & Immunotherapeutics Pub Date : 2024-09-15 DOI:10.1080/21645515.2024.2395081

Bassel Akache, Michael J. McCluskie

引用次数: 0

Abstract

Archaeosomes are liposomes traditionally comprised of total polar lipids or semi-synthetic glycerolipids of ether-linked isoprenoid phytanyl cores with varied glycol- and amino-head groups. We have...

查看原文本刊更多论文

作为疫苗佐剂的硫酸化乳糖古菌素（SLA）古菌体

考古体是一种脂质体，传统上由全极性脂质或半合成甘油脂质组成，其核心是具有不同乙二醇和氨基头基的醚键异戊二烯植物烷基。我们已经...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

自引率

8.30%

发文量

审稿时长

1 months

期刊介绍： (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.